What is NDC 31722-373?

31722-373 is the product NDC for Plerixafor, Plerixafor 24 mg/1.2mL injection, solution, listed with the FDA by Camber Pharmaceuticals, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.

Camber Pharmaceuticals, Inc., NDC labeler code 31722. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Plerixafor?

11 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Plerixafor NDC 31722-373 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)31722-373Labeler and product segments. Claims need a package NDC.

Product NDC at billing width31722-0373Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
31722-373-31	31722037331	1 VIAL, SINGLE-USE in 1 CARTON (31722-373-31) / 1.2 mL in 1 VIAL, SINGLE-USEMarketed from Jun 16, 2025

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Plerixafor
Generic name (nonproprietary): plerixafor
Active ingredients: Plerixafor — 24 mg/1.2mL
Dosage form: Injection, Solution
Route: Subcutaneous
Labeler: Camber Pharmaceuticals, Inc.NDC labeler code 31722
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 217560
Marketing start: Jun 16, 2025
Listing expires: Dec 31, 2026
Other FDA classes: Increased Hematopoietic Stem Cell Mobilization (Physiologic effect)
Identifiers: Product ID 31722-373_447a1ba3-4d5e-f506-e063-6394a90aab72SPL ID 447a1ba3-4d5e-f506-e063-6394a90aab72SPL set ID bb8e1167-8378-4e73-9bcb-d69093ec829bRxCUI 828700UNII S915P5499NUPC 0331722373319
Pharmacologic class: Hematopoietic Stem Cell Mobilizer

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N431722037331 followed by a unit qualifier and the quantity

Package 31722-0373-31. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Nov 26, 2025.

Indications (excerpt from the label)

Plerixafor injection is indicated in combination with filgrastim to mobilize hematopoietic stem cells (HSCs) to the peripheral blood for collection and subsequent autologous transplantation in patients with non-Hodgkin’s lymphoma (NHL) or multiple myeloma (MM). Plerixafor injection, a hematopoietic stem cell mobilizer, is indicated in combination with filgrastim to mobilize hematopoietic stem cells (HSCs) to the peripheral blood for collection and subsequent autologous transplantation in patients with non-Hodgkin’s lymphoma or multiple myeloma. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 31722-373

What is NDC 31722-373?: 31722-373 is the product NDC for Plerixafor, Plerixafor 24 mg/1.2mL injection, solution, listed with the FDA by Camber Pharmaceuticals, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Plerixafor.
What is the active ingredient?: Plerixafor.
Who is the labeler?: Camber Pharmaceuticals, Inc., NDC labeler code 31722. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Plerixafor?: 11 other product NDCs are listed under this name. See all Plerixafor NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Plerixafor NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Plerixafor	Plerixafor 20 mg/mL	Injection, SolutionSubcutaneous	Sagent Pharmaceuticals	25021-416	25021-0416-01
Plerixafor	Plerixafor 24 mg/1.2mL	Injection, SolutionSubcutaneous	Gland Pharma Limited	68083-155	68083-0155-01
Plerixafor	Plerixafor 24 mg/1.2mL	SolutionSubcutaneous	Dr. Reddy's Laboratories Inc	43598-308	43598-0308-23
Plerixafor	Plerixafor 24 mg/1.2mL	InjectionSubcutaneous	Zydus Pharmaceuticals USA Inc.	70710-1208	70710-1208-01
Plerixafor	Plerixafor 24 mg/1.2mL	InjectionSubcutaneous	Zydus Lifesciences Limited	70771-1776	70771-1776-01
plerixafor	Plerixafor 24 mg/1.2mL	Injection, SolutionSubcutaneous	Amneal Pharmaceuticals LLC	70121-1694	70121-1694-02
Plerixafor	Plerixafor 24 mg/1.2mL	Injection, SolutionSubcutaneous	Novadoz Pharmaceuticals LLC	72205-249	72205-0249-01
Plerixafor	Plerixafor 24 mg/1.2mL	Injection, SolutionSubcutaneous	Bryant Ranch Prepack	72162-2642	72162-2642-02
Plerixafor	Plerixafor 24 mg/1.2mL	SolutionSubcutaneous	Eugia US LLC	55150-356	55150-0356-01
Plerixafor	Plerixafor 24 mg/1.2mL	SolutionSubcutaneous	Meitheal Pharmaceuticals Inc.	71288-155	71288-0155-01

All 12 Plerixafor NDCs